Data / Form D filings / GENERICO, LLC
GENERICO, LLC: Form D filings
GENERICO, LLC, a pharmaceuticals company in St. Louis, MO, filed 2 Form D notices with the SEC between 2013 and 2015. The latest, on July 29, 2015, reports $3.8 million sold of a $6.3 million offering to 21 investors.
Find out what GENERICO, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4041 FOREST PARK AVE., St. Louis, MO, 63108
- Phone
- (847) 337-6557
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Missouri
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1577221
The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 29, 2015 | New notice | $6,259,532 | $3,759,532 | $2,500,000 | 21 | Jul 28, 2015 | sec.gov |
| May 21, 2013 | New notice | $2,500,000 | $435,000 | $2,065,000 | 3 | May 15, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Shu Zhu | Executive Officer, Director | |
| Thomas Brya | Executive Officer, Director | |
| Dan Broderick | Director | |
| Michael Grimshaw | Executive Officer, Director | |
| Philip Vogt | Executive Officer, Director |
Other pharmaceuticals companies in Missouri that filed recently
- Immunophotonics, Inc. $10.1 million · Sep 4, 2026
Every Form D from the week of Jul 27, 2015 · All recent filings in Missouri · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what GENERICO, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.